Bedrosian Camille L

Bedrosian Camille L is listed in filings as Director at Rhythm Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Mar 9, 2026, including sale activity. Recent filings connect the profile to Rhythm Pharmaceuticals, Inc. (RYTM), Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) (CRNX), and Amylyx Pharmaceuticals, Inc. (AMLX). The current snapshot covers public activity from Oct 2, 2024 to Mar 9, 2026. Reported amounts are shown as $448.0K to $36.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.